Time Slot | MAIN HALL | PARALLEL HALL |
10:00 – 12:00 | ESCV PRE-CONFERENCE WORKSHOP: Molecular Diagnostics: Harmonising Measurement for Patient Benefit * For further details regarding the workshop programme and registration, please visit the Pre-Conference Workshop page on the Conference website. | |
12:00 – 13:00 | Lunch Break | |
13:00 – 14:30 | Workshop Continue | |
14:30 – 14:50 | Coffee Break | |
14:50 – 17:00 | Workshop Continue |
Time Slot | MAIN HALL | PARALLEL HALL |
13:30 – 14:30 | SCIENTIFIC SESSION 1: Enteric viruses & Neurovirology Keynote Lecture: Enteroviruses – so much more than polio in the 21st century, Offered talk 1: One year of Europe-wide surveillance pilot for Enteroviral CNS infections, Caroline Klint Johannesen, Denmark | |
14:30 – 15:30 | SCIENTIFIC SESSION 2: Pandemic preparedness and health services research Keynote Lecture: Pandemic preparedness and health services research, Offered talk 4: Unlocking the full potential of wastewater-based epidemiology for pandemic preparedness: realistic quality assurance measures for the reliable detection of circulating and emerging viruses in wastewater, Marek Widera, Germany | |
15:30 – 16:00 | COFFEE BREAK | |
16:00 – 17:30 | SCIENTIFIC SESSION 3: Respiratory viruses Keynote Lecture: Emerging viruses – when public health, diagnostics and translational research meets, Isabella Eckerle, Switzerland Offered talk 7: Characterization of RSV full-length viral genomes after Nirsevimab breakthrough infections in a large national observational real-world study conducted in France, Marie Anne Rameix Welti, France | |
17:30 – 18:00 | Opening Ceremony | |
18:00 – 19:00 | WELCOME RECEPTION |
Time Slot | MAIN HALL | PARALLEL HALL |
08:30 – 10:00 | SCIENTIFIC SESSION 4: Offered talk 12: Multicenter benchmarking of short and long read wet lab protocols for clinical viral metagenomics, Xavier Lopez-Labrador, Spain | |
10:00 – 10:30 | COFFEE BREAK | |
10:30 – 12:00 | SCIENTIFIC SESSION 5: Offered talk 17: HCMV-specific T-cell response as a tool for predicting late HCMV reactivation in hematopoietic stem cell transplant recipients after letermovir prophylaxis, Irene Cassaniti, Italy | |
12:00 – 13:30 | LUNCH BREAK | |
12:30 – 13:30 INDUSTRY SYMPOSIUM 1 | 12:30 – 13:30 ESCV Council Meeting | |
13:30 – 15:00 | SCIENTIFIC SESSION 6: Offered talk 22: Transient biopsy-proven progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome in an elderly woman without known immunodeficiency, Christine Hanssen Rinaldo, Norway | |
15:00 – 15:30 | COFFEE BREAK | |
15:30 – 17:00 | SCIENTIFIC SESSION 7: Offered talk 27: Performance of a novel dual marker RT-qPCR- based whole-blood assay for the detection of SARS-CoV-2-reactive T cells, Franziska M. Kanis, Germany | |
17:00 – 18:00 | ENNGS Meeting | |
17:00 – 19:00 | POSTER SESSION 1 |
Time Slot | MAIN HALL | PARALLEL HALL |
08:30 – 10:00 | SCIENTIFIC SESSION 8: Development of new antiviral strategiesKeynote Lecture: Development of antiviral inhibitors of low molecular weight targeting the frameshift element of SARS-CoV-2, Harald Schwalbe, GermanyOffered talk 32: Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase 1 trial, Heikki Hyoty, Finland Offered talk 33: Development and characterisation of a novel SARS-CoV-2 macrodomain (Mac1) targeting inhibitor, Susanne Pfefferle, Germany Offered talk 34: Prevention of BK virus DNAemia by IVIG administration in at-risk kidney transplant recipients, Morgane Solis, France Offered talk 35: Brincidofovir sensitivity testing of vaccinia virus containing potential resistance associated mutations, Kevin Yeo, US Offered talk 36: Emerging host-targets for anti-mpox therapy, Denisa Bojkova, Germany | |
10:00 – 10:30 | COFFEE BREAK | |
10:30 – 12:00 | SCIENTIFIC SESSION 9: Immune response and vaccinesKeynote Lecture: Human Papillomavirus immunisation and the path to cervical cancer elimination? Kate Cuschieri, UKOffered talk 37: T-cell immunity to a conserved coronavirus epitope correlates with improved outcome of SARS-CoV-2 infection, David M. Florian, Austria Offered talk 38: IL-12 is a key responsive element to corticosteroid treatment in COVID-19, Benedikt Strunz, Sweden Offered talk 39: Specific long-term changes in anti-SARS-CoV-2 IgG modifications and antibody functions in mRNA, adenovector, and protein subunit vaccines, Sebastian Reinig, Taiwan Offered talk 40: Individual T-cell Cytokine patterns and B-cell reactions after HPV vaccination elucidated by multi-colour EliSpot, Rosemarie Preyer, Germany Offered talk 41: A Combined Cross-Sectional Analysis and Case-Control Study Evaluating Tick-Borne Encephalitis Vaccination Coverage, Disease and Vaccine Effectiveness in Children 0-17 in Switzerland, 2005-2022, Kyra Zens, Switzerland | |
12:00 – 13:30 | LUNCH BREAK | |
12:15-13:15 ENPEN Meeting | ||
POSTER SESSION 2 | ||
13:30 – 15:00 | SCIENTIFIC SESSION 10: Viral infections in pregnancyKeynote Lecture: Cytomegalovirus infection screening in pregnancy how far are we? Marianne Leurez-Ville, FranceOffered talk 42: Sequelae of congenital cytomegalovirus following maternal primary infections are limited to those acquired before 12 weeks, Jacques Fourgeaud, France Offered talk 43: Universal neonatal screening for congenital Cytomegalovirus, nine years after implementation and still going strong, Jos Van Acker, Belgium Offered talk 44: Exploring the urinary metabolomic fingerprint of human cytomegalovirus: a 1H-NMR study on congenitally infected newborns, Valentina Delloste, Italy Offered talk 45: Pichinde virus infection of pregnant guinea pigs as a comparative model of human Lassa virus infection during pregnancy, Hinh Ly, US Offered talk 46: Valacyclovir in Pregnancy To Prevent and Treat Congenital Cytomegalovirus Infection: Results from a Large Tertiary Care Hospital in Rome, Rosaria Santangelo, Italy | |
15:00 – 15:30 | COFFEE BREAK | |
15:30 – 17:00 | SCIENTIFIC SESSION 11: Emerging and re-emerging viral infections & One health Keynote Lecture: A virologist’s lookback on COVID-19, Christian Drosten, Germany Offered talk 47: High West Nile virus infection rates in mosquitoes from Berlin, 2023, Corinna Patzina Mehling, Germany | |
17:00 – 17:30 | ESCV GENERAL ASSEMBLY | |
19:30 – 23:00 | CONFERENCE NETWORKING DINNER |
Time Slot | MAIN HALL | PARALLEL HALL |
09:00 – 10:30 | SCIENTIFIC SESSION 12: Keynote Lecture: Hepatitis D Virus infection; present status, Offered talk 52: HDV infection in the UK, Will Irving, UK | |
10:30 – 11:00 | COFFEE BREAK | |
11:00 – 12:40 | SCIENTIFIC SESSION 13: Biomérieux Award Lecture: The good and the bad; update on polyoma- and anelloviruses, Mariet Feltkamp, Netherlands European Diagnostic Virology Award Lecture: Metagenomics for the diagnosis of infection, Juliane Brown, UK Heine -Medin Award Lecture: From Endemic to Pandemic: The promise and realization of real-time phylogenetics, Emma Hodcroft, Switzerland Offered talk 57: Genomic diversity of cytomegalovirus in congenital infections in France, Jacques Fourgeaud, France | |
12:40 – 13:00 | CLOSING REMARKS & HANDOVER TO ESCV 2025 |